Quarterly report pursuant to Section 13 or 15(d)

Organization and Basis of Presentation (Details Narrative)

v3.22.2.2
Organization and Basis of Presentation (Details Narrative) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Aug. 17, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Accumulated deficit   $ (43,900,000)    
Total cash   8,100,000    
Common Stock Exercise Price $ 7.00      
Net Cash Used In Operation   $ 7,000,000.0   $ 5,700,000
Sale of stock 2,571,428      
Conversion of stock 65,823,015      
Warrant exercise price   $ 7.00    
Common stock outstanding   12,102,214   8,328,629
Conversion of stock amount   $ 0 $ 6,582  
Convertible Notes [Member]        
Conversion of stock 32,219      
Accrued interest $ 5,434      
Conversion of stock amount $ 175,000      
Initial Public Offering [Member]        
Sale of stock 2,571,428      
Warrant exercise price $ 7.00      
Warrants to purchase one share of common stock 2,571,428      
Combined Offering Price $ 7.00      
Common stock outstanding 1,911,009      
Incremental number of warrants issued at IPO 385,714      
Option exercise price $ 7.00      
Gross Proceeds from warrants purchase of common stock $ 15,400,000      
Issuance costs $ 2,600,000      
Common Stock [Member]        
Conversion of stock 3,813,973      
Series 1a Preferred Stock        
Conversion of stock 1,419,228      
Warrants exercisable into common stock 69,212